Diabetes Kongress 2022
Kalender
Liste
Personen
Favoriten
zur Liste
Dr. Dominik Dahl
Diabeteszentrum Hamburg West
Germany
Vortrag
Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, is Effective and Safe When Added to Basal Insulin for Treatment of Type 2 Diabetes (SURPASS-5)
Speaker
Datum: 26.05.2022 , Zeit: 14:49
|
Thema: Poster
Details
